| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.34B | 53.52B | 52.23B | 50.70B | 42.92B | 35.08B |
| Gross Profit | 9.52B | 10.21B | 9.73B | 9.56B | 5.52B | 2.04B |
| EBITDA | 13.30B | 14.33B | 13.57B | 12.68B | 9.62B | 7.18B |
| Net Income | 4.91B | 5.80B | 5.11B | 4.57B | 2.32B | 376.43M |
Balance Sheet | ||||||
| Total Assets | 101.58B | 102.79B | 101.10B | 100.54B | 100.75B | 98.34B |
| Cash, Cash Equivalents and Short-Term Investments | 18.80B | 12.42B | 16.78B | 17.91B | 19.06B | 17.12B |
| Total Debt | 49.83B | 42.59B | 48.86B | 53.68B | 60.50B | 62.74B |
| Total Liabilities | 65.00B | 59.79B | 64.32B | 68.19B | 73.96B | 73.75B |
| Stockholders Equity | 35.48B | 41.80B | 35.69B | 31.34B | 25.88B | 23.73B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.67B | 4.13B | 6.90B | 3.83B | 1.87B |
| Operating Cash Flow | 0.00 | 11.73B | 10.84B | 13.00B | 8.97B | 6.40B |
| Investing Cash Flow | 0.00 | -8.15B | -5.86B | -5.70B | -4.83B | -4.11B |
| Financing Cash Flow | 0.00 | -8.02B | -6.12B | -8.44B | -2.21B | -2.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥682.20B | 12.68 | 8.64% | 1.82% | 0.49% | 15.11% | |
64 Neutral | ¥321.82B | 9.66 | 8.87% | 1.19% | 6.04% | 24.61% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥1.07T | 13.39 | 6.64% | 2.07% | 8.73% | 17.35% | |
58 Neutral | ¥106.73B | 19.00 | ― | 1.40% | 2.46% | 13.53% | |
58 Neutral | ¥422.04B | 10.03 | 9.06% | 2.62% | 9.72% | 3.53% | |
44 Neutral | ¥701.20B | 17.56 | ― | 1.05% | -43.04% | -83.91% |